Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Cedric Van Marcke"'
Autor:
Florian Gourgue, Françoise Derouane, Cedric van Marcke, Elodie Villar, Helene Dano, Lieven Desmet, Caroline Bouzin, Francois P. Duhoux, Patrice D. Cani, Bénédicte F. Jordan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract Obesity is a known factor increasing the risk of developing breast cancer and reducing disease free survival. In addition to these well-documented effects, recent studies have shown that obesity is also affecting response to chemotherapy. Am
Externí odkaz:
https://doaj.org/article/582848c913f2403492804f339a90a0ea
Publikováno v:
Future Science OA
Future science OA, Vol. 7, no.7, p. FSO716 (2021)
Future science OA, Vol. 7, no.7, p. FSO716 (2021)
Breast cancer is the most common malignancy occurring in women worldwide. More than 90% of patients present with localized disease are treated with curative intent; however, recurrence can occur with development of metastatic lesions. Frequently asso
Autor:
Elodie Villar, Bénédicte F. Jordan, François Duhoux, Caroline Bouzin, Hélène Dano, Françoise Derouane, Cedric Van Marcke, Florian Gourgue, Patrice D. Cani, Lieven Desmet
Publikováno v:
Scientific Reports, Vol. 11, no.1, p. 9922 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Scientific reports, Vol. 11, no.1, p. 9922 (2021)
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Scientific reports, Vol. 11, no.1, p. 9922 (2021)
Scientific Reports
Obesity is a known factor increasing the risk of developing breast cancer and reducing disease free survival. In addition to these well-documented effects, recent studies have shown that obesity is also affecting response to chemotherapy. Among the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35372ef1914ecbf55b5af41fe3b7fce3
https://hdl.handle.net/2078.1/248287
https://hdl.handle.net/2078.1/248287
Autor:
Françoise Derouane, Manon Desgres, Camilla Moroni, Jérôme Ambroise, Martine Berlière, Mieke R. Van Bockstal, Christine Galant, Cédric van Marcke, Marianela Vara-Messler, Stefan J. Hutten, Jos Jonkers, Larissa Mourao, Colinda L. G. J. Scheele, Francois P. Duhoux, Cyril Corbet
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-19 (2024)
Abstract Background Neoadjuvant chemotherapy (NAC) is the standard of care for patients with early-stage triple negative breast cancers (TNBC). However, more than half of TNBC patients do not achieve a pathological complete response (pCR) after NAC,
Externí odkaz:
https://doaj.org/article/cbcb7ddcc69b4cbbb96f42be1600415c
Autor:
Yves Guiot, Cedric Van Marcke, Benjamin Ledoux, Fanchon Noel, Latifa Fellah, François Duhoux, Mieke R. Van Bockstal, Martine Berlière, Filomena Mazzeo, Christine Galant
Publikováno v:
Annals of Diagnostic Pathology, Vol. 49, no.1, p. 151634 (2020)
A combination of Sox10 and GATA3 was previously identified as a marker for metastatic triple-negative breast cancer (TNBC), but it is uncertain whether their expression is associated with pathological complete response (pCR) after neoadjuvant chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d6dcd81fa9d7da52ca838fb6d2f051
https://hdl.handle.net/2078.1/241754
https://hdl.handle.net/2078.1/241754
Autor:
Rafael Zago Baltazar, Sofie Claerhout, Sara Vander Borght, Lien Spans, Raphael Sciot, Patrick Schöffski, Daphne Hompes, Friedl Sinnaeve, Hazem Wafa, Marleen Renard, Mari FCM van den Hout, Astrid Vernemmen, Louis Libbrecht, An‐Katrien De Roo, Filomena Mazzeo, Cédric van Marcke, Karen Deraedt, Claire Bourgain, Isabelle Vanden Bempt
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 3, Pp n/a-n/a (2024)
Abstract The identification of gene fusions has become an integral part of soft tissue and bone tumour diagnosis. We investigated the added value of targeted RNA‐based sequencing (targeted RNA‐seq, Archer FusionPlex) to our current molecular diag
Externí odkaz:
https://doaj.org/article/a4e531c2073947398417e6e0aa6c457f
Autor:
François Duhoux, Miikka Vikkula, Céline A Schoonjans, Martine Berlière, Jean-Luc Canon, Jérôme Ambroise, Raphaël Helaers, Jean-Pascal Machiels, Cedric Van Marcke, Peter Vuylsteke
Publikováno v:
Cancer Research. 80:P5-03
BACKGROUND Breast cancer (BC) is a complex disease. While Mendelian mutations in high-penetrance genes predispose to some familial forms, others are due to multiple common low-penetrance polymorphisms. However, it is unclear if the combination of som
Autor:
Aurélie Louvet, Natasha Honoré, Anne-France Dekairelle, Cédric Van Marcke, Jean-Charles Goeminne
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
A non-small-cell-lung-cancer patient with cerebral metastasis presenting an atypical exon 20 mutation in the EGFR gene had a long-lasting tumor cotrol on mulimodal treatment with osimertinib and stereotaxic radiotherapy on oligoprogressing lesions. M
Externí odkaz:
https://doaj.org/article/5236501bea2f4f72bf37b7e0977d7438
Publikováno v:
BMJ case reports. 2015
Tyrosine kinase inhibitors, represented by sunitinib, sorafenib, axitinib and pazopanib, are emerging molecules harbouring antitumoural efficacy in multiple neoplasia. We report the case of a 51-year-old woman with right thoracic sarcoma who develope
Autor:
Cédric Van Marcke, Raphaël Helaers, Anne De Leener, Ahmad Merhi, Céline A. Schoonjans, Jérôme Ambroise, Christine Galant, Paul Delrée, Françoise Rothé, Isabelle Bar, Elsa Khoury, Pascal Brouillard, Jean-Luc Canon, Peter Vuylsteke, Jean-Pascal Machiels, Martine Berlière, Nisha Limaye, Miikka Vikkula, François P. Duhoux
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-13 (2020)
Abstract Background Multigene panels are routinely used to assess for predisposing germline mutations in families at high breast cancer risk. The number of variants of unknown significance thereby identified increases with the number of sequenced gen
Externí odkaz:
https://doaj.org/article/44b3c35783f64909bdc3137b3da359fb